Background The epidemiology of human papillomavirus (HPV) in women has been well
documented. Less is known about the epidemiology of HPV in men. We aim to provide …

Despite the novel diagnostic methods and therapies implemented in oncology, the number
of patients that succumb by the cancer remains high globally. Currently studies point out that …

ABSTRACT Among women aged 27–45 years, the quadrivalent human papillomavirus
(qHPV; HPV6/11/16/18) vaccine was generally well tolerated, efficacious, and immunogenic …

Human papillomavirus (HPV) can cause several diseases, including cancers, in both sexes.
In January 2020, the Hong Kong government launched a school-based vaccination program …

It is currently recognized that in addition to the major impact of human papillomavirus (HPV)
infection in females, HPV causes considerable disease in men at the genitals, anal canal …

Background Human papillomavirus (HPV) is linked to various cancers in males and females.
The prevalence and genotype distribution of HPV vary depending on geographical region …

Background: Australia has included quadrivalent human papillomavirus (HPV) vaccination
in its national program since 2007. Significant declines have been observed in the incidence …

Background Nonavalent (9v) human papilloma virus vaccine targets high-risk human
papillomavirus (HR-HPV) types 16, 18, 31, 33, 45, 52, 58, and low-risk 6, 11. We examined …

Background Little is known about the natural history of human papillomavirus (HPV)
infection in male virgins. This study estimated the incidence and clearance of genital HPV …

Background Limited evidence indicates greater female-to-male (F–M) transmission of
genital infection with human papillomavirus (HPV) relative to male-to-female (M–F). We …